# Nilo Therapeutics

**Canonical:** https://apis.io/providers/nilo-therapeutics/  
**Website:** https://www.nilotx.com/  
**APIs profiled:** 0

Nilo Therapeutics is a New York-based, preclinical-stage biotechnology company pioneering a differentiated approach to immunomodulation by targeting the neural circuits that regulate systemic inflammation. Building on seminal discoveries from the laboratories of Charles Zuker (Columbia University / HHMI), Ruslan Medzhitov (Yale), and Stephen Liberles (Harvard) that identified vagal neurons regulating systemic immune activation, and led by CEO Kim Seth, the company harnesses the body-brain axis to restore immune homeostasis centrally, moving beyond conventional immunosuppression to treat autoimmune and inflammatory disease. Nilo launched in 2025 with a $101M Series A co-led by DCVC Bio, Lux Capital, and The Column Group, with participation from Alexandria Venture Investments and the Gates Foundation. As a therapeutics company it publishes no public developer API, SDK, or developer portal surface.

## Kin Score — 3.3 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 3.3).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Nilo Therapeutics Domain Security** — TLSv1.3 · HSTS · DNSSEC · DMARC

## Tags

Company, Biotechnology, Therapeutics, Immunology, Neuroscience, Drug Discovery, Pharmaceuticals, Healthcare

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/nilo-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.